Researchers with Therabot avatar (IMAGE)
Caption
Dartmouth scientists Michael Heinz (left) and Nicholas Jacobson (center) led the first clinical trial of an AI-powered therapy chatbot and found that, on average, people with diagnosed mental disorders experienced a significant reduction in symptoms. People in the study interacted with the software, known as Therabot, through a smartphone app where they responded to prompts from the Therabot avatar (right) or initiated conversations when they needed to talk.
Credit
Katie Lenhart, Dartmouth
Usage Restrictions
N/A
License
Original content